Literature DB >> 11325573

Properties of the 15D and EQ-5D utility measures in a community sample of people with epilepsy.

K Stavem1, H Bjørnaes, M I Lossius.   

Abstract

To perform economic evaluation studies in epilepsy using utilities, such as cost-utility analyses, it is necessary to have reliable and valid instruments for eliciting people's preferences. The objective of this study was to assess the reliability and validity of two multiattribute utility measures in a community sample of 397 people with epilepsy. We assessed the test-retest reliability of individual questionnaire items and aggregate scores. Additionally, construct validity was assessed by correlating items of the EQ-5D with items of the 15D health status questionnaire, and discriminant validity was assessed by comparing scores for known groups. The test-retest reliabilities for the individual items of the 15D (weighted kappa 0.59-0.90, except mobility with only 0.28) and the EQ-5D (weighted kappa 0.49-0.86) were acceptable. For the composite utility scores the test-retest reliability was better (intraclass correlation coefficient 0.93 for both 15D and the EQ-5D). Spearman's rank correlations between EQ-5D single item scores and corresponding 15D single item scores were high (rho 0.34-0.79) and generally higher than the associations between non-corresponding items. Some EQ-5D and 15D items discriminated well between patients according to seizure status, psychiatric comorbidity and working status; less well after antiepileptic drug use and neurologic comorbidity. Both the EQ-5D and 15D were reliable instruments and showed properties supporting the construct validity of both measures.

Entities:  

Mesh:

Year:  2001        PMID: 11325573     DOI: 10.1016/s0920-1211(01)00201-7

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  15 in total

1.  Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients.

Authors:  Lene Lunde
Journal:  Eur J Health Econ       Date:  2012-06-08

2.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.

Authors:  Knut Stavem; Stig S Frøland; Kjell B Hellum
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

3.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D.

Authors:  Samuli I Saarni; Tommi Härkänen; Harri Sintonen; Jaana Suvisaari; Seppo Koskinen; Arpo Aromaa; Jouko Lönnqvist
Journal:  Qual Life Res       Date:  2006-09-08       Impact factor: 4.147

5.  Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy.

Authors:  J T Langfitt; B G Vickrey; M P McDermott; S Messing; A T Berg; S S Spencer; M R Sperling; C W Bazil; S Shinnar
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 4.147

6.  Comparing Effectiveness of Treatments for Borderline Personality Disorder in Communal Mental Health Care: The Oulu BPD Study.

Authors:  V Leppänen; H Hakko; H Sintonen; S Lindeman
Journal:  Community Ment Health J       Date:  2015-04-01

7.  Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients.

Authors:  Christofer Lundqvist; Antonie Giæver Beiske; Ola Reiertsen; Ivar Sønbø Kristiansen
Journal:  J Neurol       Date:  2014-10-01       Impact factor: 4.849

8.  Sydney epilepsy incidence study to measure illness consequences: the SESIMIC observational epilepsy study protocol.

Authors:  Maree L Hackett; Nicholas S Glozier; Alexandra L Martiniuk; Stephen Jan; Craig S Anderson
Journal:  BMC Neurol       Date:  2011-01-09       Impact factor: 2.474

9.  Coping style and quality of life in patients with epilepsy: a cross-sectional study.

Authors:  Willemien Westerhuis; Maeike Zijlmans; Kathelijn Fischer; Judith van Andel; Frans S S Leijten
Journal:  J Neurol       Date:  2010-07-24       Impact factor: 4.849

10.  A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE).

Authors:  Feng Xie; A Simon Pickard; Paul F M Krabbe; Dennis Revicki; Rosalie Viney; Nancy Devlin; David Feeny
Journal:  Pharmacoeconomics       Date:  2015-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.